vilitra
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $7.21 | $72.11 (0%) | 🛒 Add to cart |
| 20 | $4.91 | $144.22 $98.15 (32%) | 🛒 Add to cart |
| 30 | $4.14 | $216.33 $124.19 (43%) | 🛒 Add to cart |
| 40 | $3.73 | $288.44 $149.23 (48%) | 🛒 Add to cart |
| 60 | $3.36 | $432.66 $201.31 (53%) | 🛒 Add to cart |
| 90 | $3.12 | $649.00 $280.43 (57%) | 🛒 Add to cart |
| 120 | $2.98 | $865.33 $357.55 (59%) | 🛒 Add to cart |
| 180 | $2.85
Best per pill | $1297.99 $513.79 (60%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Vilitra is an oral medication primarily indicated for erectile dysfunction, containing vardenafil as its active pharmaceutical ingredient. As a PDE5 inhibitor, it works by increasing blood flow to the penile tissues during sexual stimulation, facilitating erection achievement and maintenance. Available in various strengths including 10mg, 20mg, and 40mg tablets, this prescription medication has established itself as a reliable option in men’s sexual health management since its introduction to markets where it’s approved.
1. Introduction: What is Vilitra? Its Role in Modern Medicine
Vilitra represents a significant advancement in the pharmacological management of erectile dysfunction, belonging to the phosphodiesterase type 5 inhibitor class alongside similar medications like Levitra, which shares the same active compound. What distinguishes Vilitra in clinical practice isn’t just its mechanism—which we’ll explore in depth—but its particular pharmacokinetic profile that offers some patients a favorable balance between onset time and duration compared to other options in its class.
The medical applications of Vilitra extend beyond simply treating erectile dysfunction, with emerging evidence suggesting potential benefits for certain pulmonary hypertension cases, though this remains an off-label use that requires careful physician supervision. In my early prescribing days, I tended to view these medications as somewhat interchangeable, but over years of follow-up with hundreds of patients, I’ve observed nuanced differences in individual responses that have shaped my clinical approach.
2. Key Components and Bioavailability Vilitra
The composition of Vilitra centers on vardenafil hydrochloride as the primary active ingredient, formulated with standard pharmaceutical excipients including microcrystalline cellulose, crospovidone, colloidal silicon dioxide, and magnesium stearate. The bioavailability of vardenafil in Vilitra is approximately 15% under fasting conditions, with peak plasma concentrations achieved within 30-120 minutes post-administration.
What’s clinically relevant—and this took me some time to appreciate fully—is how significantly food affects absorption. High-fat meals can reduce Cmax by up to 18-50% and delay Tmax by up to 60 minutes. I remember one patient, David, a 52-year-old with consistent efficacy issues despite appropriate dosing. When we explored timing relative to meals, we discovered he was consistently taking his medication immediately after large dinners. Adjusting to pre-meal administration resolved his response variability.
The release form of standard Vilitra tablets differs from the orally disintegrating formulation available in some markets, which bypasses the need for water and may offer advantages for patients who prefer discretion. The composition also varies slightly between manufacturers, though bioequivalence studies generally support therapeutic interchangeability among approved generic versions.
3. Mechanism of Action Vilitra: Scientific Substantiation
Understanding how Vilitra works requires diving into the nitric oxide-cyclic guanosine monophosphate pathway. During sexual stimulation, nitric oxide release activates guanylate cyclase, increasing cyclic GMP concentrations in corpus cavernosum smooth muscle. This cascade normally leads to smooth muscle relaxation and subsequent penile vasodilation.
Phosphodiesterase type 5 enzymes break down cGMP, limiting the natural erectile response in individuals with erectile dysfunction. Vilitra’s mechanism of action centers on selective inhibition of PDE5, thereby preserving cGMP levels and enhancing the erectile response to sexual stimulation. The effects on the body are largely localized due to PDE5’s concentration in penile tissues, though mild systemic effects occur.
The scientific research behind this mechanism is robust, with numerous studies confirming PDE5 selectivity ratios that favor vardenafil’s targeted action. Interestingly, I’ve found that explaining this mechanism to patients using the “key and lock” analogy—where sexual stimulation unlocks blood flow and Vilitra keeps the pathway open—significantly improves adherence compared to when I simply prescribe without education.
4. Indications for Use: What is Vilitra Effective For?
Vilitra for Erectile Dysfunction
The primary indication for Vilitra treatment is erectile dysfunction of various etiologies. Clinical trials demonstrate efficacy rates of 70-85% across different patient populations, including those with diabetes, hypertension, and spinal cord injuries. The medication’s effectiveness for ED appears dose-dependent, with higher response rates at 20mg compared to 10mg in moderate to severe cases.
Vilitra for Pulmonary Arterial Hypertension
While not its primary indication, some studies have explored vardenafil for pulmonary hypertension treatment, typically at lower doses than used for erectile dysfunction. The vasodilatory effects that benefit penile blood flow similarly impact pulmonary vasculature, though this application remains off-label for Vilitra specifically and requires careful risk-benefit assessment.
5. Instructions for Use: Dosage and Course of Administration
Proper instructions for Vilitra use are crucial for optimal outcomes while minimizing adverse effects. The standard starting dosage is typically 10mg taken approximately 30-60 minutes before anticipated sexual activity, though individual response and tolerability should guide final dosing decisions.
| Indication | Recommended Dosage | Frequency | Administration Notes |
|---|---|---|---|
| Erectile dysfunction (initial) | 10mg | Once daily as needed | Take 30-60 minutes before sexual activity |
| Erectile dysfunction (maintenance) | 5-20mg | Once daily as needed | Adjust based on efficacy and tolerability |
| Elderly patients (65+) | 5mg | Once daily as needed | Start lower due to potential decreased clearance |
The maximum recommended dosage is 20mg once daily, and the course of administration should be regularly reevaluated, as some patients may benefit from medication holidays or alternative treatments over time. Common side effects include headache (15%), flushing (12%), nasal congestion (9%), and dyspepsia (6%), typically mild to moderate and transient.
I’ve found that creating a simple dosing schedule with patients improves adherence significantly. For John, a 68-year-old with hypertension, we established a Wednesday/Saturday pattern that aligned with his relationship dynamics and eliminated the “should I or shouldn’t I” deliberation that was causing performance anxiety.
6. Contraindications and Drug Interactions Vilitra
Absolute contraindications for Vilitra include concurrent use of nitrates in any form, due to the risk of profound hypotension. This contraindication extends to recreational amyl nitrite (“poppers”) that some patients may not disclose unless specifically asked. Additional contraindications include hypersensitivity to vardenafil or any component, and severe hepatic impairment.
Significant drug interactions with Vilitra occur with:
- Nitrate medications (isosorbide mononitrate, nitroglycerin)
- Alpha-blockers (potential additive hypotension)
- Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin)
- Grapefruit juice (may increase vardenafil concentrations)
Safety during pregnancy isn’t applicable given the medication’s indication, but men considering fatherhood should discuss use with their provider, though no significant adverse effects on sperm parameters have been demonstrated. The question “is Vilitra safe with my heart condition?” requires careful cardiovascular assessment, as sexual activity itself presents cardiac risk for unstable patients.
I learned this interaction lesson early when a patient on stable antihypertensives developed significant dizziness after adding Vilitra. We hadn’t adequately discussed timing separation from his morning alpha-blocker. No serious harm occurred, but it reinforced my commitment to thorough medication reconciliation.
7. Clinical Studies and Evidence Base Vilitra
The clinical studies supporting Vilitra’s use are extensive, with numerous randomized controlled trials establishing its efficacy and safety profile. The pivotal 12-week, flexible-dose study involving 805 men with erectile dysfunction demonstrated significantly improved erectile function scores compared to placebo, with 85% of sexual attempts successful in the treatment group versus 37% in placebo.
Scientific evidence from head-to-head trials suggests comparable efficacy between vardenafil and other PDE5 inhibitors, though individual patient responses vary considerably. One particularly illuminating study examined quality of life measures, finding that successful ED treatment with vardenafil improved relationship satisfaction scores by 42% compared to baseline.
Physician reviews increasingly emphasize the importance of patient-specific factors in medication selection. Dr. Evans, a urology colleague, once remarked during a conference that “we’ve moved beyond whether PDE5 inhibitors work to understanding which one works for whom and why.” This perspective has shaped my approach to tailoring therapy rather than applying one-size-fits-all protocols.
8. Comparing Vilitra with Similar Products and Choosing a Quality Product
When comparing Vilitra with similar products, several factors distinguish it within the PDE5 inhibitor class. Unlike sildenafil, vardenafil has less effect on PDE6 receptors, potentially reducing visual side effects. Compared to tadalafil, vardenafil offers a different duration profile that some patients prefer for planned rather than spontaneous sexual activity.
Which Vilitra is better often depends on individual patient needs, comorbidities, and concomitant medications. The decision process should consider:
- Onset and duration requirements
- Food interactions
- Side effect profile
- Cost and insurance coverage
- Patient preference
Choosing quality products requires verifying manufacturer reputation and regulatory approval status. Counterfeit medications represent a significant concern in this therapeutic area, with potentially dangerous consequences. I advise patients to obtain medications through verified pharmacies and avoid unusually low-priced options that may compromise safety.
9. Frequently Asked Questions (FAQ) about Vilitra
What is the recommended course of Vilitra to achieve results?
Most patients experience improvement within the first several doses, though optimal response may require 4-8 attempts to determine ideal timing and dose. Continuous daily use isn’t typically recommended unless specifically advised for pulmonary hypertension.
Can Vilitra be combined with alcohol?
Moderate alcohol consumption (1-2 drinks) typically doesn’t significantly impact efficacy, though excessive alcohol may increase side effect risk and impair sexual function independently.
How long does Vilitra remain effective?
The therapeutic window typically spans 4-6 hours, though individual variation exists. Sexual stimulation remains necessary throughout this period for medication efficacy.
Is Vilitra suitable for diabetic patients with ED?
Yes, Vilitra demonstrates good efficacy in diabetic erectile dysfunction, though response rates may be slightly lower than in non-diabetic populations.
10. Conclusion: Validity of Vilitra Use in Clinical Practice
The risk-benefit profile of Vilitra supports its validity in clinical practice for appropriately selected patients. With established efficacy, generally favorable tolerability, and extensive clinical experience, vardenafil remains an important option in the erectile dysfunction treatment arsenal. The key benefit of reliable erection facilitation with proper sexual stimulation makes it a valuable therapeutic tool when prescribed judiciously.
I remember when Michael first came to my clinic three years ago—a 47-year-old attorney with newly diagnosed diabetes who was struggling with erectile issues that were straining his marriage. He’d tried another PDE5 inhibitor with inconsistent results and significant nasal congestion. We switched him to Vilitra 10mg, and the difference was noticeable within two doses. What struck me wasn’t just the improved efficacy, but how the restored sexual function positively impacted his diabetes self-management motivation.
Then there was the challenging case of Robert, 71, with multiple cardiovascular comorbidities. Our cardiology team was hesitant about any ED treatment, but after thorough evaluation, we initiated Vilitra 5mg with careful monitoring. The first few months were rocky—he forgot doses, took it with high-fat meals, and reported variable results. But through persistent education and dose timing adjustment, we found his sweet spot. At his one-year follow-up, he brought his wife, who tearfully thanked me for giving them back this aspect of their relationship.
The development journey wasn’t without struggles either. I recall heated debates in our pharmacy committee about whether we should even stock multiple PDE5 inhibitors or just choose one formulary option. Dr. Wilkins argued passionately that we were overmedicalizing normal aging, while I maintained that sexual health deserved the same individualized approach we apply to other quality-of-life issues. We eventually compromised with a stepped protocol that included all options but required appropriate documentation.
The most unexpected finding over years of prescribing has been the psychological benefit that extends beyond the physical. Patients like Mark, who’d avoided relationships for years due to ED anxiety, gradually regained confidence that permeated other life areas. His two-year follow-up revealed not just successful treatment but a new relationship he attributed directly to having reliable treatment available.
These longitudinal experiences have solidified my view that while Vilitra is fundamentally a medication, its real-world impact transcends biochemical mechanisms. When James returned last month for his annual physical—our fourth year following his Vilitra treatment—he shared that what began as ED management had evolved into broader health engagement. He’d lost 25 pounds, improved his blood pressure, and was managing his prediabetes through lifestyle. “Getting that part of my life back made everything else feel possible too,” he told me. That’s the outcome no clinical trial fully captures.